Immunovant Inc (IMVT) — Financial Flexibility Index
Immunovant Inc (IMVT) has a Financial Flexibility Index of -1.06x as of June 2026. Free cash flow of $-124.41 Million (operating CF $-124.41 Million minus capex $0.00) represents -1% of total liabilities ($117.10 Million). Check Immunovant Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunovant Inc Financial Flexibility Index (2018–2026)
Historical Financial Flexibility Index trend for Immunovant Inc across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Immunovant Inc.
Annual Financial Flexibility Index for Immunovant Inc (2018–2026)
Year-by-year free cash flow to debt coverage for Immunovant Inc. Explore IMVT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -3.88x | $-407.30 Million | $-407.31 Million | $104.97 Million | ▲ +28.9% |
| 2025 | -5.45x | $-375.12 Million | $-375.87 Million | $68.78 Million | ▼ -24.8% |
| 2024 | -4.37x | $-213.87 Million | $-214.23 Million | $48.95 Million | ▼ -0.7% |
| 2023 | -4.34x | $-188.00 Million | $-188.19 Million | $43.34 Million | ▼ -87.4% |
| 2022 | -2.31x | $-105.86 Million | $-106.11 Million | $45.74 Million | ▲ +41.5% |
| 2021 | -3.96x | $-83.12 Million | $-83.33 Million | $21.01 Million | ▼ -13.6% |
| 2020 | -3.48x | $-53.33 Million | $-53.36 Million | $15.32 Million | ▲ +95.4% |
| 2019 | -74.90x | $-28.50 Million | $-28.55 Million | $380.45K | ▲ +6.0% |
| 2018 | -79.66x | $-128.25 Million | $-128.30 Million | $1.61 Million | — |